Patent ID: 7235586
Filing Date: 2007-06-26
Classification: A61K,A61P,C07C

Abstract:
1. A method of treating ocular hypertension which comprises administering to a mammal having ocular hypertension a therapeutically effective amount of a compound represented by formula I: wherein the wavy segments indicate either the α or β configuration; the dashed bond represents a double bond or a single bond; wherein W is halogen; Z is O or S; Ar is selected from the group consisting of aryl or heteroaryl radicals having from 4 to 10 carbon atoms and substituted derivatives of said aryl and heteroaryl radicals; n is 0 or an integer of from 1 to 4; x and y are 1 or 0, provided that when x is 1, y is 0 and when x is 0, y is 1; R